|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113.04 EUR | -0.18% |
|
-1.22% | +6.98% |
| 30/07 | Merck, Wellcome partner with global health group to make Ebola vaccine for clinical trials | RE |
| 28/07 | Atea Pharmaceuticals Says Combination Drug Meets Endpoints in Phase 3 Hepatitis C Trial | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.53% | -3.95% | -4.22% | +22.92% | +6.90% | +55.23% | +152.74% | +371.80% | +1,285.98% | 1,02400Cr | |
| +0.21% | -2.68% | +0.94% | +11.53% | +23.87% | +55.61% | +53.02% | +48.87% | +104.70% | 62TCr | |
| -2.51% | -3.25% | -0.28% | +18.75% | +9.83% | +32.76% | +67.76% | +115.77% | +278.89% | 44TCr | |
| +0.06% | -0.42% | +6.25% | +11.06% | +7.74% | +37.53% | +30.67% | +0.93% | +42.87% | 35TCr | |
| -0.14% | -0.24% | +0.02% | +9.23% | +15.51% | +34.41% | +39.01% | +50.93% | +57.66% | 30TCr | |
| -0.69% | -0.30% | -10.41% | -9.44% | -8.40% | +11.55% | +12.93% | +52.78% | +150.24% | 26TCr | |
| -7.37% | -4.40% | -2.57% | +12.58% | -5.76% | -2.54% | -43.87% | +5.69% | +61.70% | 21TCr | |
| -0.64% | +2.43% | +6.36% | +11.24% | +17.67% | +30.52% | +64.49% | +59.46% | +123.89% | 21TCr | |
| +0.40% | +1.92% | +3.86% | -6.33% | +0.44% | +7.39% | -30.64% | -41.58% | -32.20% | 14TCr | |
| +0.69% | +5.19% | +13.35% | +7.79% | +21.08% | +50.80% | +5.02% | -3.77% | -12.70% | 13TCr | |
| -0.95% | -0.05% | -3.95% | +11.63% | +5.24% | +4.43% | +35.41% | +136.68% | +391.86% | 12TCr | |
| -0.44% | +0.63% | -2.50% | +0.16% | +5.86% | +36.21% | +39.50% | +8.99% | -8.46% | 10TCr | |
| +2.34% | -2.05% | -0.81% | -6.70% | -9.97% | -5.54% | -23.30% | -14.28% | -2.21% | 10TCr | |
| -1.97% | -6.53% | -7.99% | -14.59% | -15.90% | -5.82% | +63.84% | +72.44% | +438.06% | 7.16TCr | |
| -3.59% | -2.39% | +6.94% | +4.61% | +14.02% | +31.26% | +27.00% | +49.73% | +20.16% | 5.52TCr | |
| -0.81% | +4.32% | -0.74% | +26.28% | +29.83% | +75.69% | -9.58% | -4.45% | -50.06% | 5.43TCr | |
| -1.04% | +1.18% | +3.92% | +0.37% | -9.22% | -14.02% | +21.31% | -0.55% | +233.75% | 5.28TCr | |
| -1.44% | -0.06% | +4.49% | +6.85% | -3.07% | +1.06% | +8.03% | - | - | 4.31TCr | |
| -1.13% | +13.63% | +3.34% | -0.17% | +12.18% | +126.60% | +316.79% | +262.80% | -34.56% | 4.08TCr | |
| Average | -1.03% | +0.09% | +0.84% | +6.20% | +6.20% | +29.64% | +43.69% | +65.12% | +169.42% | 22.81TCr | |
| Weighted average by Cap. | -0.86% | -1.45% | -0.42% | +11.49% | +8.76% | +36.71% | +62.64% | +124.31% | +395.51% |
- Stock Market
- Stocks
- GILD Stock
- GIS Stock
- Sector Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
